Harman International
Search results
Lexicon is an American company that engineers, manufactures, and markets audio equipment as a brand of Harman International Industries. The company was founded in 1971 with headquarters in Waltham, Massachusetts, and offices in Salt Lake City, Utah. It was acquired by Harman in 1993.
Steel fabrication, erection, construction, mechanical equipment installation, industrial maintenance, energy services, insulation, scaffolding, sheeting/siding… we’ve got it all under one roof to help you get it done—even the most complex of projects.
Get content ideas that drive your marketing and sales goals and empower your teams with the right collateral for the right stage. Web content, SEO, social media, explainer videos, case studies, newsletters, and more. Learn more.
© 2024 Harman International Industries, Incorporated. All rights reserved.
As the largest construction company in Arkansas, Lexicon’s more than 2,000 employees continue to set the mark as one of the nation’s leading construction and fabrication companies.
Lexicon, Inc. offers the unique capabilities of fabrication, civil, steel erection, piping and mechanical installation services under a single point of contact, eliminating the back charge path...
At Lexicon Inc., we invest heavily in our people. Discover your future career in welding, construction or management on our website.
A History of Innovation. Since 1971, Lexicon has been at the leading edge of technology, helping to innovate both professional and consumer audio. From the world’s first commercially available digital effects processor to the new Automatic Room Equalization System, each product reflects our love of music and commitment to the artistic process.
4 days ago · LXRX. LLY. AZN. Shares of Lexicon Pharmaceuticals LXRX rose more than 5% on Tuesday after the company announced that the FDA accepted its resubmitted new drug application (NDA) seeking approval ...
5 days ago · Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Through the Genome5000™ program, Lexicon’s unique genomics target discovery platform, Lexicon scientists studied the role and function of nearly 5,000 genes and identified more than 100 protein targets with significant therapeutic potential in a range of diseases. Through the precise targeting of these proteins, Lexicon is pioneering the discovery and development of innovative ...
